Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 17,874 | 15,108 | 13,777 | 12,462 | 9,652 |
| Cost of Goods | 721 | 570 | 1,764 | 660 | 967 |
| Gross Profit | 17,153 | 14,538 | 12,013 | 11,802 | 8,685 |
| Operating Expenses | 16,137 | 15,227 | 15,330 | 12,651 | 12,384 |
| Operating Income | 1,737 | -119 | -2,553 | -189 | -2,732 |
| Interest Expense | 3 | 7 | 308 | 586 | 594 |
| Other Income | 281 | 327 | -1,819 | 137 | 174 |
| Pre-tax Income | 2,015 | 201 | -4,680 | -638 | -3,152 |
| Income Tax | 42 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 1,973 | 201 | -4,786 | -638 | -3,152 |
| Net Income | $1,973 | $201 | $-4,786 | $-638 | $-3,152 |
| EPS Basic Total Ops | 0.06 | 0.01 | -0.17 | -0.02 | -0.11 |
| EPS Basic Continuous Ops | 0.06 | 0.01 | -0.16 | -0.02 | -0.11 |
| EPS Diluted Total Ops | 0.05 | 0.01 | -0.17 | -0.02 | -0.11 |
| EPS Diluted Continuous Ops | 0.05 | 0.01 | -0.16 | -0.02 | -0.11 |
| EPS Diluted Before Non-Recurring Items | 0.05 | 0.01 | -0.11 | -0.02 | -0.11 |
| EBITDA(a) | $1,762 | $-93 | $-2,500 | $-151 | $-2,694 |